CSIMarket
 
Fulcrum Therapeutics Inc   (FULC)
Other Ticker:  
 
 
Price: $10.5500 $-0.33 -3.033%
Day's High: $11.1 Week Perf: -10.74 %
Day's Low: $ 10.46 30 Day Perf: -4.09 %
Volume (M): 121 52 Wk High: $ 22.96
Volume (M$): $ 1,276 52 Wk Avg: $13.88
Open: $11.10 52 Wk Low: $7.01



 Market Capitalization (Millions $) 288
 Shares Outstanding (Millions) 27
 Employees -
 Revenues (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -23
 Cash Flow (TTM) (Millions $) -16
 Capital Exp. (TTM) (Millions $) 1

Fulcrum Therapeutics Inc


   Company Address: 26 Landsdowne Street Cambridge 2139 MA
   Company Phone Number: 651-8851   Stock Exchange / Ticker: NASDAQ FULC
   
 

Fulcrum Therapeutics Inc 's Segments
 
 

Adapthealth Corp

Adapthealth Corp announced third quarter of 2020 operating profit of $13.259 millions

In the third quarter of 2020 Adapthealth Corp lost money of $-0.04 per share compared to $-0.19 a year ago and eps fell from $0.08 per share from the previous quarter.

Sales remained unchanged to $284.41 millions from $0.00 millions in the same quarter a year ago and sequentially Sales improved by 22.53 % from $232.12 millions.

Scholar Rock Holding Corp

Scholar Rock Holding Corp announced third quarter of 2020 operating loss of $-23.618 millions

In the third quarter of 2020 Scholar Rock Holding Corp increased losses of $-0.79 per share compared to $-0.55 a year ago and increased losses from $-0.65 per share from the previous quarter.

Sales faded by -36.38% to $3.04 millions from $4.77 millions in the same quarter a year ago and sequentially Sales fell by -22.13% from $3.90 millions.

Viemed Healthcare Inc

EPS Unchanged, Sharp Topline Growth

In the third quarter of 2020 Viemed Healthcare Inc eps remained unchanged of $0.07 per share compared to $0.07 a year ago and eps dropped by -85.42% from $0.48 per share from the previous quarter.

Sales jumped by 42.18% to $33.45 millions from $23.53 millions in the same quarter a year ago and sequentially Sales fell by -21.95% from $42.85 millions.

Kiniksa Pharmaceuticals Ltd

Losses Widen but Revenues Unchanged

In the third quarter of 2020 Kiniksa Pharmaceuticals Ltd increased losses of $-0.66 per share compared to $-0.49 a year ago and increased losses from $-0.65 per share from the previous quarter.

Kiniksa Pharmaceuticals Ltd reported operating deficit of $-43.218 millions, in the third quarter of 2020, a deterioration from the operating loss of $-30.446 millions, realized in third quarter of 2019

Nikola Corporation

Nikola Corporation announced third quarter of 2020 operating loss of $-117.299 millions

In the third quarter of 2020 Nikola Corporation loss increased of $-0.31 per share compared to $0.03 a year ago and improved from $-0.33 per share from the previous quarter.

Nikola Corporation reported operating deficit of $-117.299 millions, in the third quarter of 2020, a deterioration from the operating loss of $-0.243113 millions, realized in third quarter of 2019






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WCCPRA's Profile

Stock Price

WCCPRA's Financials

Business Description

Fundamentals

Charts & Quotes

WCCPRA's News

Suppliers

WCCPRA's Competitors

Customers & Markets

Economic Indicators

WCCPRA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071